Targeting ABL kinases to regulate epithelial cell plasticity and regeneration following injury
靶向 ABL 激酶调节损伤后上皮细胞可塑性和再生
基本信息
- 批准号:10396637
- 负责人:
- 金额:$ 51.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAcuteAcute Lung InjuryAirAlveolarAlveolar CellArchitectureBacterial InfectionsBacterial PneumoniaBasal CellBiochemicalBiological AssayCell ProliferationCellsClinical effectivenessCoculture TechniquesComplementCoupledDNA DamageDataDifferentiation AntigensEpithelialEpithelial Cell ProliferationEpithelial CellsGeneticHypoxiaHypoxia Inducible FactorInflammationInjuryLiquid substanceLungLung AdenocarcinomaLung NeoplasmsMediatingModelingMusNatural regenerationNatureOrganoidsPathologicPathway interactionsPharmacologyPhosphotransferasesPlayPopulationProliferatingRegulationReportingResidual stateRoleSignal PathwaySignal TransductionSignaling MoleculeSolid NeoplasmStimulusStressTimeTissuesTranscription CoactivatorTyrosine Phosphorylationairway epitheliumairway regenerationalveolar epitheliumbronchial epitheliumcell injurycell motilitycell regenerationcell typechemotherapyeffectiveness evaluationepithelial stem cellepithelium regenerationhypoxia inducible factor 1in vivoinhibitorinjured airwayinjury and repairinsightleukemialoss of functionmouse modelnovelpathogenpneumonia modelprogenitorregeneration following injuryrepairedresponseresponse to injurystem cell proliferationstem cellstherapeutic targettranscription factortumortumorigenesis
项目摘要
ABSTRACT
Tyrosine phosphorylation networks have been implicated in the regulation of epithelial cell plasticity, which is
often induced by injury in multiple tissue types. Regeneration following injury is mediated by dynamic
intercellular signaling among diverse epithelial progenitor cell populations and residual cells. Recent studies
have revealed a significant role for cell plasticity mechanisms induced by injury where cells from one region
contribute to repair of another region after severe and acute damage. Despite the identification of multiple
region-specific progenitor cells activated following injury, the identity of molecules that might be therapeutically
targeted in response to injury to promote activation of progenitor cell types has remained elusive. We recently
showed that Abl kinases are highly activated in bronchial epithelial cells in response to pathogen-induced injury,
and that Abl inactivation in a subpopulation of airway cells promotes intercellular signaling among lung epithelial
cell progenitors to induce alveolar regeneration after bacterial pneumonia challenge. Further, we have recently
found that inhibition of Abl kinases after airway damage induced by toxic agents (SO2 exposure) promotes
basal cell proliferation and enhances differentiation. Together these data reveal for the first time a role for Abl
kinases in regeneration of both the alveolar and airway epithelium after injury by pathogens and toxic agents.
The overall hypothesis is that activation of the Abl kinases in response to injury promotes lung epithelial
damage, and that Abl inactivation in lung epithelial progenitors promotes efficient and rapid regeneration and
re-establishment of tissue architecture following injury. The specific aims are: 1. Evaluate the role of Abl kinases
in the regulation of alveolar epithelium regeneration in response to pathogen-induced injury. To this end we
will: A) evaluate the role of Abl kinases in alveolar regeneration in response to acute lung injury and assess
the effectiveness of Abl inhibitors to enhance both residual progenitor cell proliferation as well as invoking
plasticity of airway progenitors for efficient and rapid alveolar regeneration; and B) assess whether Abl1 targets
the HIF1 transcription factor in response to alveolar injury and repair. 2. Define the Abl-dependent pathways
implicated in airway epithelium regeneration. In this aim, we will A) evaluate whether Abl kinases modulate the
response of the airway epithelium during injury and whether Abl inactivation functions to promote airway
regeneration required to restore airway epithelial architecture and function; and B) identify Abl-regulated
pathways altered in the regenerating airway epithelium and evaluate the role of selected Abl targets including
Yap1 in the regulation of airway epithelial cell proliferation, differentiation, and survival after injury. These
studies break new ground as they will define novel Abl-regulated pathways activated in response to injury and
identify epithelial progenitors with enhanced cell plasticity in response to Abl inactivation, leading to
regeneration of the lung epithelium.
抽象的
酪氨酸磷酸化网络已在上皮细胞可塑性的调节中隐含
经常在多种组织类型中受伤引起。受伤后的再生是通过动态介导的
潜水员上皮祖细胞群和残留细胞之间的细胞间信号传导。最近的研究
已经揭示了受损伤引起的细胞可塑性机制的重要作用,其中一个区域的细胞
在严重和急性损坏后促进另一个区域的修复。尽管确定了多个
损伤后激活的区域特异性祖细胞,可能是热的分子的身份
响应损伤以促进祖细胞类型的激活的针对性仍然难以捉摸。我们最近
结果表明,由于病原体诱导的损伤,ABL激酶在支气管上皮细胞中被高度激活,
并且气道细胞亚群中的灭活促进了肺上皮之间的细胞间信号传导
细胞祖细胞在肺炎挑战后诱导肺泡再生。此外,我们最近有
发现在有毒剂引起的气道损伤后抑制ABL激酶(SO2暴露)会促进
基本细胞增殖并增强分化。这些数据共同揭示了ABL的角色
病原体和有毒药物损伤后牙槽和气道上皮再生的激酶。
总体假设是,响应损伤的ABL激酶的激活促进了肺上皮
损害,并且肺上皮祖细胞中的灭活促进了有效而快速再生和
受伤后的组织结构重新建立。具体目的是:1。评估ABL激酶的作用
在调节肺泡上皮再生中,响应病原体诱导的损伤。为此,我们
将:a)评估ABL激酶在急性肺损伤和评估中的作用
ABL抑制剂可以增强残留祖细胞增殖和调用的有效性
气道祖细胞的可塑性,以实现高效和快速的肺泡再生; b)评估ABL1是否目标
HIF1转录因子响应肺泡损伤和修复。 2。定义ABL依赖性途径
在气道上皮再生中实施。在此目标中,我们将a)评估ABL激酶是否调节
受伤期间气道上皮的响应以及射精灭活是否功能促进气道
恢复气道上皮架构和功能所需的再生; b)确定ABL调节
途径改变了再生气道上皮,并评估了选定的ABL目标的作用
YAP1在气道上皮细胞增殖,分化和受伤后生存中。这些
研究破裂了新的基础,因为它们将定义新的ABL调节途径,以应对伤害和
鉴定上皮祖细胞具有增强的细胞可塑性,以响应ABL灭活,导致
肺上皮的再生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ann Marie Pendergast其他文献
Ann Marie Pendergast的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ann Marie Pendergast', 18)}}的其他基金
Targeting tumor-neural cell interactions to inhibit lung cancer brain metastasis
靶向肿瘤-神经细胞相互作用抑制肺癌脑转移
- 批准号:
10164550 - 财政年份:2021
- 资助金额:
$ 51.44万 - 项目类别:
Targeting tumor-neural cell interactions to inhibit lung cancer brain metastasis
靶向肿瘤-神经细胞相互作用抑制肺癌脑转移
- 批准号:
10581652 - 财政年份:2021
- 资助金额:
$ 51.44万 - 项目类别:
Targeting tumor-neural cell interactions to inhibit lung cancer brain metastasis
靶向肿瘤-神经细胞相互作用抑制肺癌脑转移
- 批准号:
10366021 - 财政年份:2021
- 资助金额:
$ 51.44万 - 项目类别:
Targeting ABL kinases to regulate epithelial cell plasticity and regeneration following injury
靶向 ABL 激酶调节损伤后上皮细胞可塑性和再生
- 批准号:
10666351 - 财政年份:2020
- 资助金额:
$ 51.44万 - 项目类别:
Novel target for therapy refractory lung tumors
治疗难治性肺部肿瘤的新靶点
- 批准号:
9269186 - 财政年份:2015
- 资助金额:
$ 51.44万 - 项目类别:
Novel target for therapy refractory lung tumors
治疗难治性肺部肿瘤的新靶点
- 批准号:
9065535 - 财政年份:2015
- 资助金额:
$ 51.44万 - 项目类别:
Novel target for therapy refractory lung tumors
治疗难治性肺部肿瘤的新靶点
- 批准号:
8882940 - 财政年份:2015
- 资助金额:
$ 51.44万 - 项目类别:
Kinase Target of Diverse Cell Surface Receptors in Cancer Invasion and Metastasis
癌症侵袭和转移中多种细胞表面受体的激酶靶点
- 批准号:
8657899 - 财政年份:2011
- 资助金额:
$ 51.44万 - 项目类别:
Kinase Target of Diverse Cell Surface Receptors in Cancer Invasion and Metastasis
癌症侵袭和转移中多种细胞表面受体的激酶靶点
- 批准号:
8458615 - 财政年份:2011
- 资助金额:
$ 51.44万 - 项目类别:
Kinase Target of Diverse Cell Surface Receptors in Cancer Invasion and Metastasis
癌症侵袭和转移中多种细胞表面受体的激酶靶点
- 批准号:
8199099 - 财政年份:2011
- 资助金额:
$ 51.44万 - 项目类别:
相似国自然基金
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
CDK4/6抑制下调衰老中性粒细胞促炎效应改善急性肺损伤的机制和干预研究
- 批准号:82302445
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于肺间充质干细胞源外泌体lncRNA表达谱差异探讨益气活血解毒法改善脓毒症急性肺损伤的机制
- 批准号:82374400
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
基于巨噬细胞炎性小体活化探究木犀草素治疗急性肺损伤的新机制
- 批准号:82374186
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
- 批准号:82360379
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Understanding Chirality at Cell-Cell Junctions With Microscale Platforms
利用微型平台了解细胞与细胞连接处的手性
- 批准号:
10587627 - 财政年份:2023
- 资助金额:
$ 51.44万 - 项目类别:
Characterizing chemical threat agent exposures using a lung-on-a-chip platform and multi-omic analysis of common pathophysiological mechanisms
使用芯片肺平台和常见病理生理机制的多组学分析来表征化学威胁剂暴露
- 批准号:
10708553 - 财政年份:2023
- 资助金额:
$ 51.44万 - 项目类别:
Mechanical signaling through the nuclear membrane in lung alveolar health
通过核膜的机械信号传导影响肺泡健康
- 批准号:
10677169 - 财政年份:2023
- 资助金额:
$ 51.44万 - 项目类别:
p16INK4a+ fibroblasts regulate epithelial regeneration after injury in lung alveoli through the SASP
p16INK4a成纤维细胞通过SASP调节肺泡损伤后的上皮再生
- 批准号:
10643269 - 财政年份:2023
- 资助金额:
$ 51.44万 - 项目类别: